Mangoceuticals (MGRX) Retained Earnings (2023 - 2025)
Mangoceuticals (MGRX) has disclosed Retained Earnings for 3 consecutive years, with -$40.6 million as the latest value for Q4 2025.
- Quarterly Retained Earnings fell 103.19% to -$40.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$40.6 million through Dec 2025, down 103.19% year-over-year, with the annual reading at -$40.6 million for FY2025, 103.19% down from the prior year.
- Retained Earnings hit -$40.6 million in Q4 2025 for Mangoceuticals, down from -$37.9 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$70.0 in Q1 2024 to a low of -$40.6 million in Q4 2025.
- Historically, Retained Earnings has averaged -$18.5 million across 3 years, with a median of -$17.0 million in 2024.
- Biggest five-year swings in Retained Earnings: surged 100.0% in 2024 and later tumbled 37057022.86% in 2025.
- Year by year, Retained Earnings stood at -$11.2 million in 2023, then crashed by 78.16% to -$20.0 million in 2024, then plummeted by 103.19% to -$40.6 million in 2025.
- Business Quant data shows Retained Earnings for MGRX at -$40.6 million in Q4 2025, -$37.9 million in Q3 2025, and -$31.6 million in Q2 2025.